A clinical study initially carried out by Sheffield University is now being conducted by Parexel - the company involved in the disastrous clinical trials at Northwick Park.
Leading scientists have raised serious concerns about the study into the effectiveness of drugs used to treat MS.
Initially the study was being carried out by an established team at Sheffield University, but it has now been switched to Parexel - the company who was responsible for the disastrous clinical trials at Northwick Park.
A spokesperson for Alexander Harris, who are acting on behalf of the two most seriously injured participants of the Northwick Park drug trials said
"It is surprising that this study should choose to involve a company who is currently under investigation and it leaves many unanswered questions about the quality of results this study will yield."
One of the world's experts on Multiple Sclerosis (MS), whose research data was being used by the team at Sheffield University raised concern that a clinical research organisation was taking over responsibility for the trial from a group of leading scientists.
Back
Related news stories
- 05/07/2006: Northwick Park clinical drug trials - drug manufacturer Tegenero file for insolvency
- 23/03/2006: Clinical drug trials - leading clinical negligence solicitor explains
- 15/03/2006: Drug Trials - volunteers suffer multiple organ failure
- 27/02/2006: Clinical trials - confusion over compensation for injured participants
- 15/02/2005: Specialist clinical negligence solicitor adds to expertise in Solihull
If you believe that you might have a legal claim relating to this story, please complete the online enquiry form or call 0870 024 0558. Your enquiry will be forwarded to a solicitor who specialises in this area.
If you have any comments in relation to this story, please use the online discussion forum.
This news section contains stories of interest to our clients from publicly available news sources. Where we are representing the clients referred to in the news material we will say so. Where we do not represent individuals or bodies mentioned or quoted, the inclusion of the news story in our news section is not intended nor should it be taken to imply that we act for the individual or body concerned.
Related Areas
I am relieved that this is now all over and must put on record my thanks and appreciation to your firm for all your endeavours on my behalf: Chris, Shrewsbury
